Overview
Agranulocytosis is treated with 1 medication in our database, including ZARXIO. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Sandoz. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Agranulocytosis treatment below.
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
10 eventsCentre Hospitalier Universitaire de la Réunion — NA
Versailles Hospital — PHASE3
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Instituto de Investigación Biomédica de Salamanca
Shaare Zedek Medical Center — NA
Second Affiliated Hospital, School of Medicine, Zhejiang University — PHASE2
Shanxi Bethune Hospital
GERCOR - Multidisciplinary Oncology Cooperative Group — PHASE2
Case Comprehensive Cancer Center — NA
Affiliated Hospital of Nantong University — PHASE2
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
1 availableZARXIO
Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program fo
Clinical Trials
View all trials with filters →No actively recruiting trials found for Agranulocytosis at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Agranulocytosis.
Community
No community posts yet. Be the first to share your experience with Agranulocytosis.
Start the conversation →Latest news about Agranulocytosis
Disease timeline:
New recruiting trial: Real-world Study on the Prevention of Neutropenia After Tumor Treatment With Mecapegfilgrastim Injection
A new clinical trial is recruiting patients for Agranulocytosis
New recruiting trial: Early De-escalation of Empirical Antibiotics Treatment for Neutropenic Fever
A new clinical trial is recruiting patients for Agranulocytosis
New recruiting trial: Serial Blood Count Study
A new clinical trial is recruiting patients for Agranulocytosis
New recruiting trial: Adjustment of Antibiotic Dosage in Pediatric Oncology Patients With Febrile Neutropenia and Augmented Renal Clearance
A new clinical trial is recruiting patients for Agranulocytosis
New recruiting trial: Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients
A new clinical trial is recruiting patients for Agranulocytosis
New recruiting trial: Study of Trilaciclib and Lurbinectidin
A new clinical trial is recruiting patients for Agranulocytosis
New recruiting trial: Ceftolozane/Tazobactam Versus Meropenem for Febrile Neutropenia on Patients Colonized With or at Risk for Infection With Extended Spectrum Beta Lactamase - Producing Pathogens
A new clinical trial is recruiting patients for Agranulocytosis
New recruiting trial: Luspatercept for Clonal Cytopenias of Uncertain Significance
A new clinical trial is recruiting patients for Agranulocytosis
New recruiting trial: ECM and Monitoring w/ Alio Smart Patch in Cancer Pts Receiving Chemotherapy
A new clinical trial is recruiting patients for Agranulocytosis
New recruiting trial: Efficacy of Empirical Anti-Infective Therapy in Neutropenic Febrile Patients.
A new clinical trial is recruiting patients for Agranulocytosis
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Agranulocytosis
What is Agranulocytosis?
Agranulocytosis is treated with 1 medication in our database, including ZARXIO. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Sandoz. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Agranulocytosis treatment below.
Which specialists treat Agranulocytosis?
25 specialists and care centers treating Agranulocytosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.
What treatment and support options exist for Agranulocytosis?
1 FDA-approved treatment are currently tracked on UniteRare for Agranulocytosis. See the treatments and support programs sections for copay assistance, eligibility, and contact details.